Design, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy.
Journal
ACS omega
ISSN: 2470-1343
Titre abrégé: ACS Omega
Pays: United States
ID NLM: 101691658
Informations de publication
Date de publication:
06 Jun 2023
06 Jun 2023
Historique:
received:
06
04
2023
accepted:
15
05
2023
medline:
12
6
2023
pubmed:
12
6
2023
entrez:
12
6
2023
Statut:
epublish
Résumé
In an endeavor to identify small molecules for the management of non-small-cell lung carcinoma, 10 new hydrazone derivatives (
Identifiants
pubmed: 37305321
doi: 10.1021/acsomega.3c02331
pmc: PMC10249096
doi:
Types de publication
Journal Article
Langues
eng
Pagination
20056-20065Informations de copyright
© 2023 The Authors. Published by American Chemical Society.
Déclaration de conflit d'intérêts
The authors declare no competing financial interest.
Références
BMC Chem. 2023 Mar 24;17(1):26
pubmed: 36964610
Infect Disord Drug Targets. 2015;15(2):76-88
pubmed: 26205803
Arch Pharm (Weinheim). 2019 Jun;352(6):e1800365
pubmed: 31115928
J Med Chem. 2022 Dec 22;65(24):16033-16061
pubmed: 36503229
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
pubmed: 6606682
Med Oncol. 2022 Jul 14;39(10):147
pubmed: 35834033
Bioorg Med Chem Lett. 2016 Jul 1;26(13):3067-3072
pubmed: 27209235
Int J Mol Sci. 2016 May 31;17(6):
pubmed: 27258253
Eur J Med Chem. 2019 Mar 15;166:291-303
pubmed: 30731398
J Mol Biol. 2007 Mar 30;367(3):882-94
pubmed: 17275837
J Agric Food Chem. 2011 Sep 28;59(18):10286-97
pubmed: 21877710
Molecules. 2018 Dec 12;23(12):
pubmed: 30545123
J Pharm Pharmacol. 2020 Jul;72(7):927-937
pubmed: 32301120
Bioorg Chem. 2020 Mar;96:103593
pubmed: 32004897
ChemMedChem. 2021 Nov 5;16(21):3237-3262
pubmed: 34289258
Int J Mol Sci. 2023 Jan 31;24(3):
pubmed: 36768971
Drug Dev Res. 2023 Apr;84(2):185-199
pubmed: 36469421
Front Oncol. 2018 Jul 24;8:267
pubmed: 30087852
SLAS Technol. 2019 Apr;24(2):161-168
pubmed: 30744468
J Med Chem. 2006 Oct 19;49(21):6177-96
pubmed: 17034125
Pharmacology. 2019;104(5-6):244-257
pubmed: 31494659
Anticancer Agents Med Chem. 2017;17(4):608-614
pubmed: 27456663
Chem Rev. 2011 Nov 9;111(11):6783-809
pubmed: 21774490
Eur J Med Chem. 2018 Jan 20;144:444-492
pubmed: 29288945
Front Oncol. 2020 Nov 11;10:585284
pubmed: 33262947
Bioorg Chem. 2017 Oct;74:82-90
pubmed: 28772160
Cancer Res. 2019 Mar 15;79(6):1019-1031
pubmed: 30808672
J Enzyme Inhib Med Chem. 2022 Dec;37(1):2063-2077
pubmed: 35875937
Arch Pharm Res. 2016 Feb;39(2):191-201
pubmed: 26694484
Molecules. 2018 May 31;23(6):
pubmed: 29857484
Eur J Med Chem. 2015 Jun 5;97:778-85
pubmed: 25487760
Curr Drug Targets. 2015;16(13):1448-63
pubmed: 24875380
Molecules. 2021 Jul 05;26(13):
pubmed: 34279440
Nat Rev Clin Oncol. 2010 Jul;7(7):401-14
pubmed: 20551945
Molecules. 2007 Aug 17;12(8):1910-39
pubmed: 17960096
Life Sci. 2020 Aug 15;255:117816
pubmed: 32454155
Med Chem Res. 2017;26(2):287-301
pubmed: 28163562
SAR QSAR Environ Res. 2012;23(3-4):345-55
pubmed: 22490049
Int J Oncol. 2016 Mar;48(3):869-85
pubmed: 26698230